Silence Therapeutics: Of The Current Report On Form 8k Filed On December 15, 2025 (the “original Form 8k”) To Disclose Information Regarding Material Modifications To A Material Compensatory Plan, Contract Or Arrangement As To Which A Named Executive Officer Of The Registrant Participates That Were Effected Pursuant To An Agreement Entered Into Subsequent To The Filing Of The Original Form 8k. No Other Changes Have Been Made To The Original Form 8k

Mostra articolo completo

Questa funzionalità è disponibile solo per gli utenti registrati

• Nome completo dell'emittente
  Silence Therapeutics PLC
• Paese di registrazione
  United Kingdom
• Settore industriale
  Pharmaceutical Preparation and Biotechnology
• М/S&P/F
  *** / *** / ***